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Background 
Historically, exercise tolerance testing (ETT) has provided clinicians with valuable diagnostic and 
prognostic information in the assessment of the patient with cardiac disease. More recently, with 
the emergence of advanced cardiac imaging modalities (i.e. nuclear imaging, stress 
echocardiography and MRI), the limitations of ETT in the detection of coronary ischemia have all but 
confirmed its inevitable demise. Clinical decision making from ETT relies predominantly on the 
interpretation of the ECG and patient reported symptoms in relation to an increasing exercise 
workload. Cardiopulmonary exercise testing (CPEX) offers a superior evaluation of a patient’s 
integrated cardiovascular, respiratory and metabolic response to exercise by combining the standard 
measures of electrocardiography, blood pressure, O2 saturation and exercise workload with 
ventilatory gas exchange data. Generally performed on a static bike, patients are required to wear a 
small facemask which enables the analysis of respired gases for the real-time, breath by breath 
determination of oxygen uptake (VO2), carbon dioxide production (VCO2) and minute ventilation 
(VE). Collective observation of the relationship between these variables, and their comparison to 
population norms, offers a unique insight into the cardiovascular, pulmonary and metabolic 
response to exercise. Conducted over a test duration of 9-12 minutes, CPEX utilises a ramp protocol 
which involves a gradual and continuous increase in workload at a rate of 5-15 watts/minute in 
clinical populations.  The patient is required to exercise until either fatigue, or the development of 
clinical symptoms, prevents continuation. 
 
Figure 1 – patient on bike 
 
Clinical indications for CPEX 
With vast improvements in technology, the utility of CPEX has evolved rapidly over the past decade 
from relative ambiguity as a research tool, to an ever more present and broadly applicable 
assessment in clinical practice.  Currently its use extends to differential diagnosis in the exercise 
intolerant patient, assessment of perioperative risk prior to vascular and other surgeries, 
determination of prognosis and eligibility for cardiac transplant in CHF, and for effective prescription 
in exercise rehabilitation.  Ultimately, in conjunction with other clinical assessments, it ably 
contributes to the holistic management of patients with complex disease. Within the field of 
cardiology in the UK, CPEX is under-utilised, most commonly conducted to establish clinical status in 
the CHF patient rather than to quantify the impact of coronary disease. In this regard, CPEX offers 
compelling diagnostic and prognostic information, and is equally effective in the assessment of the 
therapeutic benefit of pharmacological, electrophysiological or rehabilitative intervention. Recent 
data, also confirms increased sensitivity and specificity in the detection of coronary ischemia, over 
and above that of standard ETT. With the current trend in cardiac imaging it appears unlikely that 
CPEX will be widely adopted for the diagnosis of coronary ischemia in the near future but it should 
not be overlooked when considering that it is vastly cheaper, quicker and significantly less invasive 
than current tests.  CPEX also has undoubted potential for the prescription of metabolic threshold 
based exercise in cardiac rehabilitation. There is considerable support for the notion that more 
accurate and effective exercise interventions may be delivered when prescription is determined by 




Clinical indications for CPEX 
Differential diagnosis in patients with exercise limitation 
Assessment of perioperative risk 
Grading severity and establishing prognosis in heart failure 
Assessing need for cardiac transplant 
Assessing efficacy of therapeutic intervention 
Exercise prescription for rehabilitation 
 
 
The physiology of exercise 
In order that the true value of CPEX may be appreciated, an understanding of the underlying 
physiological response to exercise is useful. The completion of sustained muscular work is reliant on 
the delivery of O2 to the working muscle. The presence of O2 at the muscle mitochondria, allows 
adenosine triphosphate (ATP) to be enzymatically split to release energy for exercise.  Skeletal 
muscle stores of ATP are limited, and thus O2 is further required during cellular respiration for the 
ongoing resynthesis of ATP from carbohydrates and fats.  The CO2 produced as a by-product of 
cellular respiration is comfortably ventilated during moderate intensity aerobic exercise. With 
increasing exercise intensity, however, energy production becomes more reliant on anaerobic 
pathways. A much increased ventilatory drive is required to expel additional CO2 produced by 
bicarbonate buffering during lactic acidosis that results from the anaerobic resynthesis of ATP.  The 
combined effects of lactic acidosis, in particular muscular fatigue, ensure that exercise becomes 
uncomfortable and ultimately unsustainable. Therefore, the transport and utilisation of O2 is key to 
the successful completion of exercise. In order for this to be optimised, the integrity of the heart, 
lungs, blood vessels and the blood must be maintained.  Inadequacy in any one or any combination 
of these factors will limit the efficiency with which exercise can be performed. 
 
External respiration is tightly coupled to cellular respiration 
Maximal oxygen consumption during exercise (VO2 max) is an integrated measure of 
cardiorespiratory fitness and a powerful predictor of disease morbidity and mortality. Essential to 
the achievement of an appropriate VO2 max, is a good cardiac output, a healthy blood oxygen 
concentration, an efficient distribution of blood to the working muscles and refined O2 extraction at 
the muscle.  External respiration, i.e. VO2 and VCO2 measured at the mouth by CPEX, is inextricably 
linked to cellular respiration (described above) thus providing a ‘window’ into O2 delivery and 
utilisation by the muscle and CO2 production and delivery to the lungs. When this data is combined 
with measurement of minute ventilation, heart rate and workload, the performance and 
competence of the organ systems coupling cellular and external respiration can be assessed. This 
allows CPEX to differentiate between exercise limitation caused by cardiovascular or respiratory 
disease and even to distinguish between different cardiovascular diseases.  For example, chronic 
heart failure, coronary artery disease and peripheral vascular disease all have unique CPEX data 
profiles. It should be noted that skilled interpretation of CPEX results is required when considering 
differential diagnosis, and the addition of the more invasive measurement of arterial blood gases 
during CPEX significantly increases the accuracy of some diagnoses. 
 
Figure 2 - wasserman diagram of the integrated physiological response to exercise 
 
Summary: the role of CPEX in the NHS 
Through the analysis of the relationship between external and cellular respiration, CPEX provides an 
integrated assessment of the multiple organ systems required for the completion of physical 
exercise. The evaluation of physiological function during exercise has the ability to unmask 
pathology which is otherwise occult when investigated at rest. In an increasingly comorbid 
population, the use of CPEX as a first line investigation offers a cheap, quick and comparatively less 
invasive modality for the simultaneous assessment of multiple organ systems.  Completion of CPEX 
offers the physician the potential to assess multiple organ competence with a single test, isolating 
and/or excluding pathology, thus efficiently directing future investigations and avoiding needless 
additional tests. Not only does this reduce the impact on the patient, but it provides a cost effective 
solution for the NHS, reducing the financial burden of multiple investigations.  In cardiology 
specifically, CPEX has an established place in the systematic assessment for cardiac transplant. 
Potential exists for a broader remit whereby CPEX could be used for the detection of coronary 
ischemia, which if confirmed as sufficiently accurate in future studies, would provide a compelling 
alternative to invasive and expensive nuclear imaging. Relatively speaking, the use of CPEX in clinical 
practice is still in its infancy, but it is highly likely that its application will become ever more frequent. 
